2.10.2024

Sustainable finance is vital for achieving the objectives of the green transition

Sustainable finance has developed rapidly in recent years. Financing has been systematically directed towards investments in line with sustainable development and green transition objectives across the entire financing sector from bank finance to direct lending.

The Action Plan for Sustainable Finance that the European Commission published in 2018 has led the regulatory tsunami in the EU, resulting in a vast body of sustainable finance-related regulation. For example, ESMA’s implementation timeline for sustainable finance includes steps up to 2028, even though its major regulatory packages have been completed. At the same time, the principles of the LMA and ICMA have also gained in popularity and provided a strong basis for self-regulation in the industry that is widely followed.

In the light of these developments, there is a need in sustainable finance for a standardised definition of ‘green’ and a taxonomy of green activities to enable investors and financial institutions to make informed assessments effectively. This is why the future EU Green Bond Standard will be based specifically on the EU taxonomy regulation. The European Banking Authority also published a report in December 2023 where it recommended that the Commission introduce a voluntary standard for European green loans or at least a definition of green loans in the EU. The Commission is currently considering this report and further actions.

The above initiatives and regulatory developments can be seen as a result of the greenwashing debate. Greenwashing is currently being discussed by investors, financiers and other market participants alike. At the same time, the green transition is progressing rapidly, and sustainable finance is needed to meet the objectives. The European Commission estimates that by 2030 an additional EUR 620 billion of investments will be needed every year. Sustainable finance is therefore a vital condition for the realisation of these investments. We are following the progress of the green transition objectives and the regulation of sustainable finance with interest.

Latest references

Hiab acquisition financing
We are advising Hiab Corporation in the financing for its USD 1,035 million acquisition of Labrie Environmental Group, a leading North American refuse collection vehicle (“RCV”) manufacturer, from Wynnchurch Capital, L.P. Hiab Corporation (Nasdaq Helsinki: HIAB) is a leading provider of smart and sustainable on-road load handling solutions, with 2025 sales of approximately EUR 1.6 billion and approximately 4,000 employees, operating through a global network spanning over 100 countries. Labrie Group is a leading North American provider of RCVs, employing approximately 1,200 people. 
Case published 1.6.2026
We advised an international bank syndicate in a EUR 300 million revolving credit facility (RCF) for ICEYE, the world leader in sovereign intelligence from space. The bank-syndicate comprised Nordic and global banks, with Citi and Danske Bank acting as Joint Global Coordinators and Mandated Lead Arrangers. The RCF will support the issuance of guarantees for customer contracts, enable continued business growth, and serve as a liquidity backstop. 
Case published 21.5.2026
We advised Huhtamäki Oyj on its issuance of a EUR 300 million 6-year senior unsecured bond under the EMTN programme and on the tender offer of its EUR 500 million senior unsecured bond maturing in 2027. The new bond bears interest at a fixed rate of 3.875 per cent per annum. Huhtamäki used the net proceeds from the issuance of the new bond for the partial repurchase of its bond maturing in 2027 and for general corporate purposes.
Case published 21.5.2026
We advised Aurevia Oy, a portfolio company of French private equity sponsor Mérieux Equity Partners, in a strategic reorganisation that involved splitting Aurevia and its parent companies into two independent groups of companies and reorganisation of its existing debt-financing arrangements. Following the reorganisation, the newly formed Aurevia continues as a leading provider of Contract Research Organization (CRO) and Quality Assurance and Regulatory Affairs (QARA) services, while the newly formed Labquality focuses on delivering External Quality Assessment (EQA) services. Aurevia serves operators in the medical devices, in vitro diagnostics and pharmaceutical sectors. Labquality’s customers include clinical laboratories and social and healthcare organisations. The reorganisation positions Aurevia and Labquality to allocate investments more effectively, accelerate growth within their respective customer segments, and respond to evolving market and client needs. The transaction was implemented through multiple parallel demergers and required comprehensive legal and tax structuring across several jurisdictions. Our team supported Aurevia throughout the planning and implementation phases, covering corporate, tax, employment law, and regulatory matters, as well as the optimisation of each group’s financing structure.
Case published 7.4.2026